Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scalp photography helps patients feel less anxious about hair loss, agree more with doctors on severity, and stay motivated for treatment.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

The document's conclusion cannot be provided because the content is not available.

Stress, diet, and environment can worsen scalp seborrheic dermatitis.

Scalp microbiota changes may be linked to inflammation in Alopecia Areata.

SSD patients have unique allergen sensitivities linked to skin and microbiota changes.

Allergen reactivity in scalp seborrheic dermatitis should be managed with barrier repair and microbiome-focused strategies.

The AI device accurately grades scalp exfoliation and can help diagnose scalp disorders.

Combining scalp photos with hair density and caliber measurements gives a more accurate assessment of hair loss.

Traction alopecia reduces hair density and thickness; proper hair care can help prevent it.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Chinese women's hair gets thinner and grayer with age, and scalp conditions change, especially after 40.

A reliable severity score for female pattern hair loss was developed and validated.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

AI can accurately measure hair loss severity in alopecia areata.

Alopecia areata severity is influenced by hair loss, emotional, and financial burdens.

Deep learning and explainable AI are improving scalp disorder diagnosis, but challenges in transparency and data quality remain.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Androgenetic alopecia may increase the severity of COVID-19.

Higher sebum levels are linked to more severe male baldness.